Navigation Links
Bioniche Reports the Passing of its Board Chair
Date:4/18/2008

- Hy Isenbaum served as Chair of the Bioniche Board of Directors since 1999

-

BELLEVILLE, ON, April 18 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that its long-time Board Chair, Mr. Hy Isenbaum, has passed away.

"This is very sad news for Bioniche Life Sciences," said Graeme McRae, the Company's President & CEO. "As Board Chair, Mr. Isenbaum contributed financial expertise and vigilance regarding the Company's financial statements. Additionally, he has provided a high level, conservative, ethical tone that permeates the whole Company in terms of regulatory affairs, product development, and overall conduct of the business. He will be greatly missed by all who knew and worked with him. He was a mentor and a friend."

Mr. Isenbaum was Chair of the Board since 1999, when Bioniche Life Sciences Inc. was formed through an amalgamation of Bioniche Inc., Renaissance Life Sciences Inc., and Vetrepharm Animal Health Inc.

Mr. Isenbaum was a Fellow Chartered Accountant and the Founder of the firm Soberman, Isenbaum and Colomby. As the Managing Partner, a position he held until 1993, he built his firm to be the 15th largest accounting practice in Canada. He was a Chairman of the Board and Chairman Emeritus of the Mount Sinai Hospital in Toronto. He was appointed by the Ontario Ministry of Health as Ombudsman to the Medical Review Committee of the College of Physicians and Surgeons. He served on the Board of Directors of the Samuel Lumenfeld Research Institute in Toronto and was instrumental in the establishment of the Institute. Mr. Isenbaum was also a Governor of the Weizman Institute of Science in Israel and sat on the boards of a number of private and public companies.

In honour of Mr. Isenbaum's extensive contributions to Bioniche, the "Hy Isenbaum Award" has been created. This will be presen
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Bioniche Converts a Portion of its Debt to Equity
2. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
3. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
4. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
5. Bioniche Reports Fiscal 2008 Second Quarter
6. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
7. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Reports Fiscal 2008 First Quarter
10. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
11. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Essential tremor (ET) is the most common ... people in the United States, and millions more worldwide. ... causes ET, there are no medications specifically designed to ... Tremor© is the International Essential Tremor Foundation’s annual research ... cure for this life-altering neurological condition. , “Although millions ...
(Date:6/17/2013)... of people who registered themselves as organ donors 21-fold ... social media might be an effective tool to address ... The gains were made in May 2012 when the ... share their organ donor status with friends and provided ... department of motor vehicle websites. The findings are being ...
(Date:6/17/2013)... June 17, 2013 Bust’DD (pronounced ‘busted’), a ... and well-fitting to women with large busts, will soon launch ... two women who understand the problem of ill-fitting bras and ... women. Their goal is to raise at least $25,000 to ... offering their bras on a wide scale. , In order ...
(Date:6/17/2013)... 2013 The producers of Impact with ... of reports highlighting how sustainable farming techniques are helping ... and their demand on food supplies. , Impact ... series airing in markets around the country on public ... Sheen, who is marking the start of his second ...
(Date:6/17/2013)... As da Vinci robot lawsuit claims ... Liebhard LLP notes that a recent report aired on ... disturbing robotic surgery complications alleged to have been caused by ... June 14th broadcast revealed that the U.S. Food & Drug ... Vinci patients who suffered burns, cuts and infections since 2007. ...
Breaking Medicine News(10 mins):Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 3Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 3
... the Children of Love Canal Are Not Counted In the ... Speak &,Ask What Have We Learned?, FALLS CHURCH, Va., ... for Health, Environment & Justice:, WHAT:, Press Conference ... Love Canal once stood., Rain or Shine, WHEN:, ...
... YORK, July 26, 2008 The following news tips are ... 2008 International Conference to be held in Chicago from July ... specific date and time. , Brain Atrophy and Biomarkers ... Susan de Santi, Ph.D., Associate Professor, Department of Psychiatry, NYU ...
... FE SPRINGS, Calif., July 29 IQAir announced ... (USOC) with ultra-high,efficiency air cleaning for USA athletes ... the optimum performance environment., (Photo: http://www.newscom.com/cgi-bin/prnh/20080729/LATU099 ... able to support the performance efforts of the,USOC ...
... SAN JOSE, Calif., July 29 VNUS(R) Medical,Technologies, Inc. (Nasdaq: ... for the full year 2008. Full-year 2008 net income is ... income of $0.77,to $0.85 per share which is changed from ... or income of $0.68 to $0.74 per,share., ABOUT VNUS ...
... AGAWAM, Mass., July 29 Microtest Laboratories has,launched ... compounding pharmacies,in the U.S. that have yet failed ... 797) regulations. Microtest also announced,its offer of a ... USP 797 compliance level and corresponding,preparation., Pharmacies ...
... Health and Charitable Care and Coverage, OAKLAND, ... it has approved more than 415 community benefit ... second quarter of 2008.,The quarter,s contributions continue to ... a measurable impact on the health of,its communities., ...
Cached Medicine News:Health News:30 Years After State of Emergency Declared at Love Canal, NY Closing the 99th Street School Triggering the Federal Superfund Program; Schools & Communities Across the Nation Still at Risk of Toxic Contamination 2Health News:New Alzheimer's predictors advance earlier detection 2Health News:New Alzheimer's predictors advance earlier detection 3Health News:New Alzheimer's predictors advance earlier detection 4Health News:New Alzheimer's predictors advance earlier detection 5Health News:New Alzheimer's predictors advance earlier detection 6Health News:New Alzheimer's predictors advance earlier detection 7Health News:New Alzheimer's predictors advance earlier detection 8Health News:IQAir to Provide U.S. Athletes With Ultra-High Efficiency Air Cleaning at the Beijing 2008 Olympic Games 2Health News:VNUS Revises Upward Full-Year 2008 Net Income Guidance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 3Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 2Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 3
(Date:6/17/2013)... June 17, 2013  As the Share Repurchase Resolution has ... Offer for Elan Corporation, plc (NYSE: ELN ) ... outcome of the Proceedings referred to below and any consequent ... to be effective to the extent that it would have ... of the Share Repurchase Resolution being passed. There can be ...
(Date:6/17/2013)... PARSIPPANY, N.J. , June 17, 2013 Actavis, ... United States Supreme Court has reversed the decision of the ... affirmed the District Court,s ruling granting Actavis, motion to dismiss ... .  The Supreme Court,s reversal was the result of a ... the FTC,s proposed "quick look" approach and adopted the traditional ...
(Date:6/17/2013)... , June 17, 2013 The Biozoom ... portable, hand held device for the non-invasive transdermal ... human body. It replaces expensive, time consuming and ... a button, the Biozoom scanner reflects a beam ... Zeiss—and measures the reflection. Using the scanner, researchers ...
Breaking Medicine Technology:Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 2Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 3Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 4Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 5Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 6Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 7Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 8Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 9Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 10U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 2University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 4
... Sheffield Bio-Science, a leading global pharmaceutical supplier of superior ... markets, has been awarded the distinguished 2010 Lilly Global Supplier Award. ... The ... and services for Eli Lilly and Company over the years and ...
... ATLANTA , July 12 Holon, the new ... Medication Management solution. , ... Leveraging the Holon Process Adaptive Interoperability Framework, ... your current medication management solution by automating the collection and ...
Cached Medicine Technology:Sheffield Bio-Science Wins 2010 Lilly Global Supplier Award 2Holon: The Process Adaptive Interoperability Framework 2
... The QuickVue Influenza A+B test allows ... influenza type A and type B ... wash and/or nasal aspirate specimens. The ... in the rapid differential diagnosis of ...
... Antibody Detection Assay is a single use, ... (first step) detection of IgG and IgM ... or whole blood. Rapid turnaround time, ease ... Wampole PreVue B. burgdorferi antibody detection test ...
... Conforming to U.S. and international ... Nephew's TC-100 Screw and Plating System* ... and ease of use for open ... However, the TC-100 system works well ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: